Association of β-1 and β-2 adrenergic receptor gene polymorphisms with myocardial infarction

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 4, 2009, Pages 237-243

  Yilmaz, Akin ^a   Kaya, Mehmet G ^a   Merdanoglu, Ulgen ^a   Ergun, Mehmet A ^a   Cengel, Atiye ^a   Menevse, Sevda ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

ADRB1; ADRB2; Myocardial infarction; Polymorphism

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; SERINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ST SEGMENT ELEVATION; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS; TURKEY;

EID: 68049083395     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20327     Document Type: Article

References (35)

1. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999;51:651-690.
2. Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors: Physiological and pathophysiological relevance. J Pharmacol Sci 2006;100:323-337. (Pubitemid 44609527)
3. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembranespanning receptors and heart function. Nature 2002;415:206-212.
4. Taylor MR. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics J 2007;7:29-37.
5. Humma LM, Puckett BJ, Richardson HE, et al. Effects of beta 1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001;88:1034-1037.
6. Ranade K, Jorgenson E, Sheu WH, et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002;70:935-942. (Pubitemid 34259309)
7. Borjesson M, Magnusson Y, Hjalmarson A, Andersson B. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000;21:1853-1858.
8. Covolo L, Gelatti U, Metra M, et al. Role of beta1- and beta2- adrenoceptor polymorphisms in heart failure: A case-control study. Eur Heart J 2004;25:1534-1541. (Pubitemid 39165632)
9. Nonen S, Okamoto H, Akino M, et al. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population. Br J Clin Pharmacol 2005;60:414-417.
10. Shin J, Lobmeyer MT, Gong Y, et al. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007;99:250-255.
11. Tesson F, Charron P, Peuchmaurd M, et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999;31:1025-1032. (Pubitemid 29241538)
12. Podlowski S, Wenzel K, Luther HP, et al. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000;78:87-93.
13. Iwai C, Akita H, Kanazawa K, et al. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction. Am Heart J 2003;146:106-109. (Pubitemid 36851307)
14. Bengtsson K, Melander O, Orho-Melander M, et al. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation 2001;104:187-190.
15. Herrmann SM, Nicaud V, Tiret L, et al. Polymorphisms of the beta2 -adrenoceptor (ADRB2) gene and essential hypertension: The ECTIM and PEGASE studies. J Hypertens 2002;20:229-235. (Pubitemid 34913787)
16. Galletti F, Iacone R, Ragone E, et al. Lack of association between polymorphisms in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti Heart Study. Am J Hypertens 2004;17:718-720. (Pubitemid 39091554)
17. Sala G, Di Castelnuovo A, Cuomo L, et al. The E27 beta2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males. Thromb Haemost 2001;85:231-233. (Pubitemid 32140565)
18. Heckbert SR, Hindorff LA, Edwards KL, et al. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003;107:2021-2024. (Pubitemid 36506077)
19. Wallerstedt SM, Eriksson AL, Ohlsson C, Hedner T. Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population. J Hum Hypertens 2005;19:705-708. (Pubitemid 43118093)
20. Zee RY, Cook NR, Reynolds R, Cheng S, Ridker PM. Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics 2005;169:1583-1587. (Pubitemid 40547466)
21. Liggett SB, Wagoner LE, Craft LL, et al. The Ile164 beta2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-1539.
22. Ulucan C, Cetintas V, Tetik A, et al. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias. J Cardiovasc Electrophysiol 2008;19:1053-1058.
23. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003;43:381-411. (Pubitemid 37372647)
24. Rathz DA, Brown KM, Kramer LA, Liggett SB. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002;39: 155-160.
25. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 2002;277: 30429-30435. (Pubitemid 34970733)
26. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 1999;274: 12670-12674. (Pubitemid 129518037)
27. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9419. (Pubitemid 24272896)
28. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046. (Pubitemid 24106561)
29. Lloyd-Jones DM, Nam BH, D'Agostino Sr. RB, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: A prospective study of parents and offspring. J Am Med Assoc 2004;291:2204-2211. (Pubitemid 38608169)
30. Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of beta1-adrenoceptor: Identification and rapid screening assay. Lancet 1999;353:897. (Pubitemid 29126881)
31. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: A web tool for the analysis of association studies. Bioinformatics 2006;22:1928-1929. (Pubitemid 44283043)
32. White HL, Maqbool A, McMahon AD, et al. An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. Eur Heart J 2002;23:1087-1092.
33. Stanzione R, Angelantonio E, Evangelista A, et al. β2-Adrenergic receptor gene polymorphisms and risk of ischemic stroke. Am J Hypertens 2007;20:657-662. (Pubitemid 46777261)
34. Forleo C, Resta N, Sorrentino S, et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med 2004;117:451-458. (Pubitemid 39349582)
35. Forleo C, Sorrentino S, Guida P, et al. Beta1- and beta2- adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy. J Cardiovasc Med 2007;8: 589-595. (Pubitemid 47222172)